[go: up one dir, main page]

AU2001240109A1 - Dna vaccines against poxviruses - Google Patents

Dna vaccines against poxviruses

Info

Publication number
AU2001240109A1
AU2001240109A1 AU2001240109A AU4010901A AU2001240109A1 AU 2001240109 A1 AU2001240109 A1 AU 2001240109A1 AU 2001240109 A AU2001240109 A AU 2001240109A AU 4010901 A AU4010901 A AU 4010901A AU 2001240109 A1 AU2001240109 A1 AU 2001240109A1
Authority
AU
Australia
Prior art keywords
dna vaccines
vaccines against
against poxviruses
poxviruses
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240109A
Inventor
Jay W. Hooper
Alan L. Schmaljohn
Connie S. Schmaljohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Army Medical Research Institute of Infectious Diseases
Original Assignee
US Army Medical Research Institute of Infectious Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Army Medical Research Institute of Infectious Diseases filed Critical US Army Medical Research Institute of Infectious Diseases
Publication of AU2001240109A1 publication Critical patent/AU2001240109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001240109A 2000-03-07 2001-03-07 Dna vaccines against poxviruses Abandoned AU2001240109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18760800P 2000-03-07 2000-03-07
US60187608 2000-03-07
PCT/US2001/007391 WO2001066138A2 (en) 2000-03-07 2001-03-07 Dna vaccines against poxviruses

Publications (1)

Publication Number Publication Date
AU2001240109A1 true AU2001240109A1 (en) 2001-09-17

Family

ID=22689681

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240109A Abandoned AU2001240109A1 (en) 2000-03-07 2001-03-07 Dna vaccines against poxviruses

Country Status (3)

Country Link
US (1) US6562376B2 (en)
AU (1) AU2001240109A1 (en)
WO (1) WO2001066138A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894155B2 (en) * 2000-10-11 2005-05-17 Viron Therapeutics Nucleic acid molecules and polypeptides for immune modulation
AU2002215727B8 (en) * 2000-12-04 2008-02-21 Viron Therapeutics Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
AU2004262506A1 (en) * 2003-02-28 2005-02-17 National Institutes Of Health Compositions, methods and kits relating to poxvirus subunit vaccines
AU2005314431B2 (en) * 2004-12-11 2011-02-17 Cytogenix, Inc. Cell free biosynthesis of high-quality nucleic acid and uses thereof
WO2006088368A2 (en) * 2005-02-15 2006-08-24 Stichting Voor De Technische Wetenschappen Dna-based coatings for implants
US7957507B2 (en) 2005-02-28 2011-06-07 Cadman Patrick F Method and apparatus for modulating a radiation beam
WO2006113927A2 (en) * 2005-04-20 2006-10-26 University Of Washington Immunogenic vaccinia peptides and methods of using same
US8232535B2 (en) 2005-05-10 2012-07-31 Tomotherapy Incorporated System and method of treating a patient with radiation therapy
EP2224008A3 (en) 2005-05-12 2010-12-01 Murdoch University Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
WO2007014106A2 (en) * 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of delivering radiation therapy to a moving region of interest
WO2007014105A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated Method and system for adapting a radiation therapy treatment plan based on a biological model
WO2007014092A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated Method of placing constraints on a deformation map and system for implementing same
KR20080039919A (en) 2005-07-22 2008-05-07 토모테라피 인코포레이티드 Systems and methods for detecting respiratory status in patients undergoing radiation therapy
WO2007014104A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of evaluating dose delivered by a radiation therapy system
US7609809B2 (en) 2005-07-22 2009-10-27 Tomo Therapy Incorporated System and method of generating contour structures using a dose volume histogram
CN101268474A (en) 2005-07-22 2008-09-17 断层放疗公司 Method and system for estimating delivered dose
US7639854B2 (en) 2005-07-22 2009-12-29 Tomotherapy Incorporated Method and system for processing data relating to a radiation therapy treatment plan
JP2009502254A (en) * 2005-07-22 2009-01-29 トモセラピー・インコーポレーテッド Systems and methods for monitoring the operation of medical devices.
WO2007014094A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated Method of and system for predicting dose delivery
US8442287B2 (en) 2005-07-22 2013-05-14 Tomotherapy Incorporated Method and system for evaluating quality assurance criteria in delivery of a treatment plan
JP2009502255A (en) 2005-07-22 2009-01-29 トモセラピー・インコーポレーテッド Method and system for assessing quality assurance criteria in the delivery of treatment plans
CA2616293A1 (en) 2005-07-23 2007-02-01 Tomotherapy Incorporated Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
US7790182B2 (en) * 2005-09-21 2010-09-07 The United States Of America As Represented By The Secretary Of The Army Protein vaccines against poxviruses
EP2314619A1 (en) * 2005-12-05 2011-04-27 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US8052968B2 (en) 2006-10-16 2011-11-08 Genelux Corporation Modified vaccinia virus strains for use in diagnostic and therapeutic methods
WO2008100508A2 (en) 2007-02-12 2008-08-21 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of The United States Army Medical Research Institute Of Infectious Diseases Puumala virus full-length m segment-based dna vaccines
WO2009009039A2 (en) * 2007-07-09 2009-01-15 The Usa, As Represented By The Secretary Of The Army, On Behalf Of The United States Army Medical Research Compositions containing full-length l1r nucleic acid and endoplasmic reticulum targeting sequence
JP2010535030A (en) 2007-08-03 2010-11-18 スピロジーン ピーティーワイ エルティーディー Novel genes and proteins of Brachyspira hyodysenteriae and their use
US7807180B2 (en) * 2007-08-21 2010-10-05 University Of Massachusetts Poxvirus methods and compositions
GB0720250D0 (en) 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
US8795667B2 (en) * 2007-12-19 2014-08-05 Macrogenics, Inc. Compositions for the prevention and treatment of smallpox
EP2363407A1 (en) 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
WO2009117773A1 (en) 2008-03-27 2009-10-01 Murdoch University Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
EP2303312B1 (en) * 2008-05-28 2016-03-30 Inovio Pharmaceuticals, Inc. Smallpox dna vaccine and the antigens therein that elicit an immune response
DK3156069T3 (en) 2008-06-20 2020-09-21 Univ Duke COMPOSITIONS, PROCEDURES, AND KITS FOR INDUCING AN IMMUNE RESPONSE
US9315826B2 (en) 2011-01-31 2016-04-19 The United States of America as rep. by the Sec'y of the Army, for U.S. Army Medical Research Institute of Infectious Diseases Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene
EP2962309B1 (en) 2013-02-26 2022-02-16 Accuray, Inc. Electromagnetically actuated multi-leaf collimator
US9861681B2 (en) 2013-04-18 2018-01-09 The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases Therapeutic compositions for neutralizing type I interferons, and methods of use
CN116082521B (en) * 2022-12-02 2024-04-02 中国科学院微生物研究所 Poxvirus multi-antigen chimeric vaccines and their uses

Also Published As

Publication number Publication date
WO2001066138A3 (en) 2002-03-14
US6562376B2 (en) 2003-05-13
WO2001066138A2 (en) 2001-09-13
US20020176871A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
AU2001240109A1 (en) Dna vaccines against poxviruses
AU2002336760A1 (en) Mutable vaccines
GB0020953D0 (en) Vaccine
AU1591402A (en) Vaccine
AU2001258279A1 (en) Adjuvant for vaccines
AU2002254558A1 (en) Novel vaccine
AU2002322059A1 (en) Improved vaccination against anthrax
AUPQ520800A0 (en) Prime-boost vaccination strategy
AU2001244687A1 (en) Micro-array
AU5977700A (en) Vaccines
AU2002249823A1 (en) Acne vaccine
AU2001267541A1 (en) Vaccine composition
AU2002254161A1 (en) M cell directed vaccines
AU2002236065A1 (en) Papillomavirus vaccines
GB0014845D0 (en) Vaccine
AU2002222139A1 (en) Hcv vaccines
AU2002347346A1 (en) Dna vaccine
GB0003082D0 (en) Vaccine
AU2001266534A1 (en) Papillomavirus vaccine
AU2767201A (en) M cell directed vaccines
AU2001285421A1 (en) Vaccine against rsv
AU2002322013A1 (en) Therapeutic dna vaccination
AU5084300A (en) New vaccine formulations - 1
GB0015722D0 (en) Vaccine
AU2002319485A1 (en) Dna vaccine